TSC1 and head and neck squamous cell carcinoma: Afatinib inhibits mTOR through the ROS/DNA damage responses 1/tuberous sclerosis 1 (ROS/REDD1/TSC1) axis, stimulates protective autophagy in HNSCC cells, and diminishes their susceptibility to cell death [67].